Literature DB >> 6604229

Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes.

C G Brooks.   

Abstract

Natural killer (NK) activity is a poorly understood component of the immune system, generally identified as the ability to kill certain tumour cells. Perhaps the most controversial issue has been the lineage to which cells displaying this activity belong. Extensive studies of surface antigens on cells with NK activity in both mouse and man have led to enigmatic results, such cells apparently bearing markers of both T-cell (Thy-1 and E receptor) and myeloid (Mac-1 and OKM1) lineages. A fresh approach to this problem would be to take cells of known lineage and test whether they express, or could be induced to express, NK cell function. Using this approach we show here that monoclonal cytotoxic T lymphocyte (CTL) lines can be induced, by culture in high concentrations of spleen cell supernatant, to express a new lytic activity apparently identical with that of splenic cells NK activity. Preliminary evidence implicates both interleukin-2 (IL-2) and interferon (IFN) as mediators of this phenomenon. These findings clearly demonstrate that cells of T cell lineage have the capacity to express NK activity.

Entities:  

Mesh:

Year:  1983        PMID: 6604229      PMCID: PMC7094994          DOI: 10.1038/305155a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Studies on the induction and expression of T cell-mediated immunity. V. Lectin-induced nonspecific cell-mediated cytotoxicity by alloimmune lymphocytes.

Authors:  B Bonavida; T P Bradley
Journal:  Transplantation       Date:  1976-02       Impact factor: 4.939

Review 2.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

3.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

4.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

5.  Characterization of a lymphoma cell variant selectively resistant to natural killer cells.

Authors:  J M Durdik; B N Beck; E A Clark; C S Henney
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

Review 6.  Molecular characterization of interleukin 2.

Authors:  S Gillis; D Y Mochizuki; P J Conlon; S H Hefeneider; C A Ramthun; A E Gillis; M B Frank; C S Henney; J D Watson
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  Inhibition of cytotoxic T lymphocyte activity by concanavalin A.

Authors:  M V Sitkovsky; M S Pasternack; H N Eisen
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.

Authors:  K Handa; R Suzuki; H Matsui; Y Shimizu; K Kumagai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.

Authors:  J M Zarling; P C Kung
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

10.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Authors:  A L Glasebrook; F W Fitch
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  28 in total

1.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

2.  Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.

Authors:  F Ronchese; D Collavo; P Zanovello; V Cerundolo; G Biasi
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

3.  Isolation and functional characterization of chicken intestinal intra-epithelial lymphocytes showing natural killer cell activity against tumour target cells.

Authors:  J Y Chai; H S Lillehoj
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

4.  Studies concerning the relationship of Pichinde virus-induced natural killer cells and cytotoxic T lymphocytes.

Authors:  K L Rosenthal; C Steiner; W E Rawls; C M Walker
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Generation of natural killer cells from bone marrow precursors in vitro.

Authors:  T Kalland
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

6.  Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

Authors:  L Matera; R Foa; F Malavasi; G Bellone; A Funaro; F Veglia; D Santoli
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 7.  T cell receptor gene rearrangements in cells with natural killer activity in the mouse.

Authors:  R J Lauzon; K A Siminovitch; J C Roder
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  The ovarian follicle as a model for the cell-mediated control of tissue growth.

Authors:  A Bukovský; J Presl; M Holub
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

9.  AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.

Authors:  K Taniguchi; Y I Kawano; K Nomoto
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

10.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.